Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral calcium tablets to prevent citrate-related adverse effects in PBPC collection from healthy donors
jRCTs061220096Active, not recruiting
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of calcium in Citrate Toxicity (2 arms). Primary endpoint: Incidence of citrate-related adverse effects (Grade ≥1). Started Jul 2023; status: active, not recruiting.
02
Drugs
calcium
03
Conditions
Citrate Toxicity
Beyond the preview
Go deeper on jRCTs061220096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220096.